Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia

Nutrition and Cancer
Leslie FischerS H Zeisel

Abstract

A phase I clinical trial was conducted to determine the safety, pharmacokinetic parameters, and efficacy of orally administered isoflavones (genistein and daidzein, potential cancer chemotherapeutic agents) over a 3-mo period in men with prostate neoplasia. Twenty men, ages 40 and above, with stage B, C, or D adenocarcinoma of the prostate were treated with a multiple-dose regimen of a soy isoflavone formulation (delivering approximately 300 or 600 mg/day genistein and half this much daidzein) for 84 days. The delivered dose of isoflavones was more than 10-fold higher than that typically taken by prostate cancer patients. In men with prostate cancer, relatively minor side effects of chronic isoflavone treatment were observed including some estrogenic effects (breast changes, increased frequency of hot flashes). Serum dehydroepiandrosterone was decreased by 31.7% (P = 0.0004) at the end of treatment. Except for those subjects whose prostate-specific antigen (PSA) values were below 0.4 ng/ml, subjects had a history of increasing PSA levels prior to the trial. This increase continued during the trial both while on soy isoflavones and after treatment was discontinued. On average the rate of rise accelerated after soy isoflavones we...Continue Reading

Associated Clinical Trials

Nov 15, 2013·Sofya PintovaSofya Pintova

References

Apr 1, 1982·Journal of Pharmaceutical Sciences·D Perrier, M Gibaldi
May 16, 1998·The American Journal of Clinical Nutrition·R A King, D B Bursill
Dec 16, 1998·The American Journal of Clinical Nutrition·D G ThiagarajanF A Kavas
Dec 16, 1998·The American Journal of Clinical Nutrition·L J Lu, K E Anderson
Mar 20, 1999·The Journal of Nutrition·K D Setchell, A Cassidy
Apr 14, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G I SaltiA I Constantinou
Sep 28, 2000·Biochemical and Biophysical Research Communications·H S YoonY H Yoo
Jan 5, 2002·The American Journal of Clinical Nutrition·Marjorie G BusbySteven H Zeisel
Jul 4, 2002·Annals of the New York Academy of Sciences·H Leon Bradlow, Daniel W Sepkovic
Jul 12, 2002·The Urologic Clinics of North America·Erik P Castle, J Brantley Thrasher
Sep 28, 2002·Urology·Leonard S MarksVarro E Tyler
Oct 26, 2002·The American Journal of Clinical Nutrition·LeAnne T BloedonSteven H Zeisel
Apr 17, 2004·Nutrition and Cancer·Maha HussainOmer Kucuk

❮ Previous
Next ❯

Citations

Aug 24, 2010·Cancer Metastasis Reviews·Janet M PaveseRaymond C Bergan
Oct 10, 2007·Prostate Cancer and Prostatic Diseases·F G E PeraboP J Bastian
Nov 16, 2007·Nutrition and Cancer·Nagi B KumarJulio Pow-Sang
Oct 7, 2010·Nutrition and Cancer·Nurdan TacyildizOmer Kucuk
May 25, 2013·Nutrition and Cancer·Dhanya Nambiar, Rana P Singh
Jul 30, 2009·Journal of the National Cancer Institute·Li XuRaymond C Bergan
Sep 10, 2008·PPAR Research·Ioannis SainisEvangelos Briasoulis
Apr 1, 2010·Toxins·Maria RussoGian Luigi Russo
Oct 1, 2011·The American Journal of Clinical Nutrition·Kenneth D R SetchellMark J Messina
Oct 28, 2011·The Journal of Nutrition·Trevor E QuinerMerrill J Christensen
Jun 10, 2009·Expert Opinion on Investigational Drugs·Huanjie YangQ Ping Dou
Oct 7, 2016·International Journal of Radiation Biology·Shin-Ichi BandoKen Ohnishi
Dec 15, 2005·Nutrition and Cancer·Sanjeev Shukla, Sanjay Gupta
Sep 13, 2006·Nutrition and Cancer·Mark MessinaAnna H Wu
Sep 24, 2009·Molecular Nutrition & Food Research·Alicja MortensenGerhard Sontag
Nov 30, 2006·International Journal of Cancer. Journal International Du Cancer·Sarah C ThomassetAndreas J Gescher
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·Akira Murakami, Hajime Ohigashi
Jan 21, 2009·Der Urologe. Ausg. A·F G E PeraboP J Bastian
Jan 30, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Kishore K Katyayan, Yu-Hua Hui
Feb 21, 2007·Prostate Cancer and Prostatic Diseases·M A GoetzlJ B Thrasher
Dec 15, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Nicole V SoucySusan J Borghoff
Jan 1, 2014·Cancer Metastasis Reviews·Yiwei LiFazlul H Sarkar
May 30, 2014·The American Journal of Clinical Nutrition·Janet M PaveseRaymond C Bergan
Mar 22, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ludmila KřížováTomáš Kašparovský
Nov 7, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tomislav PejčićŽivoslav Tešić
Aug 23, 2020·Nutrients·Inés Domínguez-LópezSara Hurtado-Barroso
Nov 1, 2016·Molecular Neurobiology·Kasi Pandima DeviSeyed Mohammad Nabavi
Aug 15, 2012·Journal of Nutrition in Gerontology and Geriatrics·Donato F Romagnolo, Ornella I Selmin
Apr 20, 2018·Phytotherapy Research : PTR·Bahare SalehiJavad Sharifi-Rad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.